Clinical Trial Update: R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL [Phase 3]

View source ↗

Summary

Phase 3 trial comparing R-CHOP plus R-HAD versus R-CHOP followed by maintenance lenalidomide plus rituximab, with an additional maintenance rituximab arm, in ol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (doxorubicin)
• Lenalidomide (lenalidomide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Mantle Cell Lymphoma | Phase 3 | Status: COMPLETED